IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022 - IGC Pharma, INC.

Press

Releases

February 14, 2023

IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022

Related Posts

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

May 12, 2025

IGC Pharma Welcomes Strategic Investment from Advisors

April 24, 2025

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer’s Innovation and AI-Driven Programs

April 21, 2025

CEO Update

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

May 12, 2025

IGC Pharma Welcomes Strategic Investment from Advisors

April 24, 2025